Fibromuscular dysplasia MRI: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Fibromuscular dysplasia}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Refere...")
 
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Fibromuscular dysplasia}}
{{Fibromuscular dysplasia}}


Please help WikiDoc by adding more content hereIt's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}}; {{AE}}{{M.B}}
 
==Overview==
[[Magnetic resonance angiography]] (MRA) in comparison with [[Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis|DUS]] and [[CT angiography|CTA]] is less preferred, due to an inadequate spatial resolution in the branch vessels, and pseudobeading features from artifact impact. However, [[Magnetic resonance angiography|MRA]] can be useful for detecting [[Aneurysm|aneurysms]] and [[Dissection (medical)|dissections]].
 
==Magnetic Resonance Angiography==
[[Magnetic resonance angiography]] (MRA) in comparison with [[Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis|DUS]] and [[CT angiography|CTA]] is less preferred, due to an inadequate spatial resolution in the branch vessels, and pseudobeading features from artifact impact. However, [[Magnetic resonance angiography|MRA]] can be useful for detecting [[Aneurysm|aneurysms]] and [[Dissection (medical)|dissections]].<ref name="OlinGornik2014">{{cite journal|last1=Olin|first1=J. W.|last2=Gornik|first2=H. L.|last3=Bacharach|first3=J. M.|last4=Biller|first4=J.|last5=Fine|first5=L. J.|last6=Gray|first6=B. H.|last7=Gray|first7=W. A.|last8=Gupta|first8=R.|last9=Hamburg|first9=N. M.|last10=Katzen|first10=B. T.|last11=Lookstein|first11=R. A.|last12=Lumsden|first12=A. B.|last13=Newburger|first13=J. W.|last14=Rundek|first14=T.|last15=Sperati|first15=C. J.|last16=Stanley|first16=J. C.|title=Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions: A Scientific Statement From the American Heart Association|journal=Circulation|volume=129|issue=9|year=2014|pages=1048–1078|issn=0009-7322|doi=10.1161/01.cir.0000442577.96802.8c}}</ref>
 
 
According to AHA guideline, MRA of the head should be performed in all patients with cervicocranial FMD. [[Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis|DUS]] may reveal an irregular [[stenosis]] of the [[Carotid arteries|carotid]] or [[Vertebral artery|vertebral arteries]] compatible with FMD. However, [[CT angiography|CTA]] and [[Magnetic resonance angiography|MRA]] are likely to perform better, especially because FMD usually affects the middle and distal portions of the carotid and vertebral arteries, which are less accessible to DUS. Moreover, CTA and MRA have the advantage to allow the detection of associated [[intracranial aneurysms]].<ref name="O'ConnorGornik2014">{{cite journal|last1=O'Connor|first1=S. C.|last2=Gornik|first2=H. L.|title=Recent Developments in the Understanding and Management of Fibromuscular Dysplasia|journal=Journal of the American Heart Association|volume=3|issue=6|year=2014|pages=e001259–e001259|issn=2047-9980|doi=10.1161/JAHA.114.001259}}</ref>
 


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Kidney diseases]]
[[Category:Nephrology]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]

Latest revision as of 04:37, 1 August 2018

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia MRI

CDC on Fibromuscular dysplasia MRI

Fibromuscular dysplasia MRI in the news

Blogs on Fibromuscular dysplasia MRI

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

Magnetic resonance angiography (MRA) in comparison with DUS and CTA is less preferred, due to an inadequate spatial resolution in the branch vessels, and pseudobeading features from artifact impact. However, MRA can be useful for detecting aneurysms and dissections.

Magnetic Resonance Angiography

Magnetic resonance angiography (MRA) in comparison with DUS and CTA is less preferred, due to an inadequate spatial resolution in the branch vessels, and pseudobeading features from artifact impact. However, MRA can be useful for detecting aneurysms and dissections.[1]


According to AHA guideline, MRA of the head should be performed in all patients with cervicocranial FMD. DUS may reveal an irregular stenosis of the carotid or vertebral arteries compatible with FMD. However, CTA and MRA are likely to perform better, especially because FMD usually affects the middle and distal portions of the carotid and vertebral arteries, which are less accessible to DUS. Moreover, CTA and MRA have the advantage to allow the detection of associated intracranial aneurysms.[2]


References

  1. Olin, J. W.; Gornik, H. L.; Bacharach, J. M.; Biller, J.; Fine, L. J.; Gray, B. H.; Gray, W. A.; Gupta, R.; Hamburg, N. M.; Katzen, B. T.; Lookstein, R. A.; Lumsden, A. B.; Newburger, J. W.; Rundek, T.; Sperati, C. J.; Stanley, J. C. (2014). "Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions: A Scientific Statement From the American Heart Association". Circulation. 129 (9): 1048–1078. doi:10.1161/01.cir.0000442577.96802.8c. ISSN 0009-7322.
  2. O'Connor, S. C.; Gornik, H. L. (2014). "Recent Developments in the Understanding and Management of Fibromuscular Dysplasia". Journal of the American Heart Association. 3 (6): e001259–e001259. doi:10.1161/JAHA.114.001259. ISSN 2047-9980.

Template:WH Template:WS